Core Viewpoint - Gulfport Energy reported quarterly earnings of $4.24 per share, missing the Zacks Consensus Estimate of $5.03 per share, representing an earnings surprise of -15.71% [1] - The company posted revenues of $447.62 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 33.79% [2] Financial Performance - Earnings per share (EPS) for the same quarter last year was $2.91, indicating a year-over-year increase [1] - Gulfport has surpassed consensus EPS estimates three times over the last four quarters [2] - The company has topped consensus revenue estimates just once over the last four quarters [2] Stock Performance - Gulfport shares have declined approximately 9.4% since the beginning of the year, while the S&P 500 has gained 7.6% [3] - The current Zacks Rank for Gulfport is 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $6.29, with expected revenues of $366.77 million [7] - For the current fiscal year, the consensus EPS estimate is $22.78 on revenues of $1.44 billion [7] - The outlook for the industry, specifically the Oil and Gas - Exploration and Production - United States sector, is currently in the bottom 31% of Zacks industries, which may impact Gulfport's stock performance [8]

Company Performance - Myriad Genetics reported quarterly earnings of $0.05 per share, exceeding the Zacks Consensus Estimate of a loss of $0.01 per share, representing an earnings surprise of +600.00% [1] - The company posted revenues of $213.1 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 5.55% and showing a slight increase from $211.5 million year-over-year [2] - Over the last four quarters, Myriad has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times as well [2] Stock Outlook - Myriad shares have declined approximately 71% since the beginning of the year, contrasting with the S&P 500's gain of 7.6% [3] - The current consensus EPS estimate for the upcoming quarter is $0.01 on revenues of $205.1 million, while for the current fiscal year, the estimate is -$0.01 on revenues of $811.68 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Myriad belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Myriad's stock performance [5]

Core Viewpoint - Gossamer Bio reported a quarterly loss of $0.17 per share, slightly better than the Zacks Consensus Estimate of a loss of $0.18, marking an earnings surprise of +5.56% [1] - The company has consistently surpassed consensus EPS estimates over the last four quarters [2] Financial Performance - Gossamer Bio posted revenues of $11.49 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 155.88%, compared to revenues of $95.84 million a year ago [2] - The company has also topped consensus revenue estimates four times in the last four quarters [2] Stock Performance - Gossamer Bio shares have increased approximately 139.9% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.6% [3] Future Outlook - The company's earnings outlook will be crucial for investors, particularly in understanding how current consensus earnings expectations may evolve [4] - The current consensus EPS estimate for the upcoming quarter is -$0.18 on revenues of $5.78 million, and for the current fiscal year, it is -$0.69 on revenues of $28.57 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Gossamer Bio belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, indicating potential challenges ahead [8]

Group 1 - Lucid Group reported a quarterly loss of $0.28 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.22, representing an earnings surprise of -27.27% [1] - The company posted revenues of $259.43 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 2.37%, and showing an increase from $200.58 million year-over-year [2] - Over the last four quarters, Lucid Group has surpassed consensus revenue estimates three times [2] Group 2 - The stock has underperformed, losing about 20.2% since the beginning of the year, while the S&P 500 has gained 7.6% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.26 on revenues of $375.43 million, and for the current fiscal year, it is -$0.89 on revenues of $1.31 billion [7] - The Zacks Industry Rank for Automotive - Domestic is currently in the bottom 29% of over 250 Zacks industries, indicating potential challenges for the sector [8]

Core Insights - United Fire Group (UFCS) reported quarterly earnings of $0.9 per share, exceeding the Zacks Consensus Estimate of $0.57 per share, and showing a significant improvement from a loss of $0.07 per share a year ago, resulting in an earnings surprise of +57.89% [1] - The company posted revenues of $335.47 million for the quarter ended June 2025, which was slightly below the Zacks Consensus Estimate by 1.1%, but an increase from $301.17 million in the same quarter last year [2] - United Fire has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.77, with projected revenues of $347.3 million, while the estimate for the current fiscal year stands at $2.50 on revenues of $1.37 billion [7] - The company's earnings outlook will be influenced by management's commentary during the earnings call, which is crucial for understanding future stock performance [3][4] Industry Context - The Insurance - Property and Casualty industry, to which United Fire belongs, is currently ranked in the bottom 42% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of United Fire's stock may be affected by the overall industry outlook, as historical data shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Financial Performance - Portillo's Inc. reported quarterly earnings of $0.12 per share, matching the Zacks Consensus Estimate, and an increase from $0.10 per share a year ago [1] - The company posted revenues of $188.46 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 3.5%, but up from $181.86 million year-over-year [2] - Over the last four quarters, Portillo's has surpassed consensus EPS estimates three times, while it has topped consensus revenue estimates only once [2][3] Market Performance - Portillo's shares have increased by approximately 1% since the beginning of the year, compared to a 7.6% gain in the S&P 500 [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.09 on revenues of $196.28 million, and for the current fiscal year, it is $0.36 on revenues of $779.09 million [7] - The outlook for the Retail - Restaurants industry, where Portillo's operates, is currently in the top 41% of Zacks industries, suggesting a favorable environment for stock performance [8]

Core Insights - Shift4 Payments reported quarterly earnings of $1.1 per share, missing the Zacks Consensus Estimate of $1.2 per share, but showing an increase from $0.96 per share a year ago, resulting in an earnings surprise of -8.33% [1] - The company posted revenues of $413.4 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.40% and increasing from $320.6 million year-over-year [2] - Shift4 Payments shares have underperformed the market, losing about 1.5% since the beginning of the year compared to the S&P 500's gain of 7.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.43 on revenues of $440.66 million, and for the current fiscal year, it is $5.52 on revenues of $1.76 billion [7] - The estimate revisions trend for Shift4 Payments was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Financial Transaction Services industry, to which Shift4 Payments belongs, is currently in the bottom 40% of the Zacks Industry Rank, suggesting potential challenges for stock performance [8] - Another company in the same industry, PAR Technology, is expected to report quarterly earnings of $0.04 per share, reflecting a year-over-year change of +117.4%, with revenues projected to be $107.94 million, up 38.1% from the previous year [9][10]

Core Insights - Neuronetics reported a quarterly loss of $0.15 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.08, marking an earnings surprise of -87.50% [1] - The company generated revenues of $38.11 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 3.87% and significantly up from $16.45 million a year ago [2] - Neuronetics shares have increased approximately 189.4% year-to-date, outperforming the S&P 500's gain of 7.6% [3] Financial Performance - Over the last four quarters, Neuronetics has consistently failed to meet consensus EPS estimates [2] - The current consensus EPS estimate for the upcoming quarter is -$0.07 on revenues of $39.04 million, and for the current fiscal year, it is -$0.37 on revenues of $150.72 million [7] Industry Context - Neuronetics operates within the Medical - Instruments industry, which is currently ranked in the bottom 37% of over 250 Zacks industries [8] - The performance of Neuronetics' stock may be influenced by the overall outlook of the industry, as top-ranked industries tend to outperform lower-ranked ones by a factor of more than 2 to 1 [8]

分组1 - AxoGen reported quarterly earnings of $0.12 per share, exceeding the Zacks Consensus Estimate of $0.06 per share, and showing an increase from $0.05 per share a year ago, resulting in an earnings surprise of +100.00% [1] - The company achieved revenues of $56.66 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 7.11%, and up from $47.91 million year-over-year [2] - Over the last four quarters, AxoGen has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] 分组2 - The stock has underperformed, losing about 23.9% since the beginning of the year, while the S&P 500 has gained 7.6% [3] - The current consensus EPS estimate for the coming quarter is $0.07 on revenues of $55.93 million, and for the current fiscal year, it is $0.20 on revenues of $216.4 million [7] - The Zacks Industry Rank for Medical - Instruments is currently in the bottom 37% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]

Company Performance - Graham reported quarterly earnings of $0.45 per share, exceeding the Zacks Consensus Estimate of $0.25 per share, and up from $0.33 per share a year ago, representing an earnings surprise of +80.00% [1] - The company achieved revenues of $55.49 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.57% and increasing from $49.95 million year-over-year [2] - Over the last four quarters, Graham has consistently surpassed consensus EPS estimates and topped revenue estimates three times [2] Stock Movement and Outlook - Graham shares have increased approximately 29.1% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.6% [3] - The future performance of Graham's stock will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.32 on revenues of $58.6 million, and for the current fiscal year, it is $1.23 on revenues of $230.3 million [7] Industry Context - The Manufacturing - General Industrial industry, to which Graham belongs, is currently ranked in the top 16% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Graham's stock performance [5][6]